The influence of modulating substances on tumor necrosis factor and interleukin-6 levels after injection of murine tumor necrosis factor or lipopolysaccharide in mice

Journal of Immunotherapy

Volumn 10, Issue 4, 1991, Pages 227-235

  Libert, Claude ^a   Bladel, Sigrid Van ^a   Brouckaert, Peter ^a   Fiers, Walter ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

D Galactosamine; Dexamethasone; Indomethacin; Interleukin 6; Lipopolysaccharide; Mice; Tumor necrosis factor

Indexed keywords

DEXAMETHASONE; GALACTOSAMINE; INDOMETACIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DRUG INTERACTION; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; DEXAMETHASONE; GALACTOSAMINE; INDOMETHACIN; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0025880739     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-199108000-00001     Document Type: Article

References (30)

1. Fiers W, Beyaert R, Brouckaert P, et al. In vitro and in vivo action of tumor necrosis factor. In: Bonavida B, Granger G, eds. Tumor necrosis factor: structure, mechanism of action, role in disease and therapy. Basel: Karger, 1990:77-81.
2. Cerami A, Beutler B. The role of cachectin/TNF in endo-toxic shock and cachexia. Immunol Today 1988;9:28-31.
3. Kettelhut IC, Fiers W, Goldberg AL. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclo-oxygenase inhibitors. Proc Natl Acad Sci USA 1987;84: 4273-7.
4. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869-71.
5. Everaerdt B, Brouckaert P, Shaw A, Fiers W. Four different interleukin-1 species sensitize to the lethal action of tumor necrosis factor. Biochem Biophys Res Commun 1989;163: 378-85.
6. Waage A, Espevik T. Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice. J Exp Med 1988;167:1987-92.
7. Rothstein JL, Schreiber H. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci USA 1988;85:607-11.
8. Bertini R, Bianchi M, Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med 1988;167:1708-12.
9. Lehmann V, Freudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987;165:657-63.
10. Marquet RL, Ijzermans JNM, De Bruin RWF, Fiers W, Jeekel J. Anti-tumor activity of recombinant mouse tumor necrosis factor (TNF) on colon cancer in rats is promoted by recombinant rat interferon gamma; toxicity is reduced by indomethacin. Int J Cancer 1987;40:550-3.
11. Goodrum KJ, Moore RN, Berry LJ. Effect of indomethacin on the response of mice to endotoxin. J Reticuloendothel Soc 1978;23:213-21.
12. Brouckaert PG, Libert C, Everaerdt B, Takahashi N, Fiers W. A role for interleukin 1 in the in vivo actions of tumor necrosis factor. Lymphokine Res 1989;8:269-74.
13. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989;169:333-8.
14. Brouckaert P, Spriggs DR, Demetri G, Kufe DW, Fiers W. Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon γ. J Exp Med 1989; 169:2257-62.
15. Guisez Y, Tison B, Vandekerckhove J, et al. Production and purification of recombinant human interleukin-6 secreted by the yeast Saccharomyces cerevisiae. Eur J Biochem 1991; 198:217-22.
16. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;95:99-105.
17. 2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 1986;83:9679-83.
18. Bradford MM. A rapid and sensitive method for the quanti-tation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
19. Galanos C, Freudenberg M, Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979;76:5939-43.
20. Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature (Lond) 1990;348:550-2.
21. Everaerdt B, Brouckaert P, Fiers W. Activity of recombinant interleukin-1 receptor antagonist (IL-lra) in mice. Implications for the role of IL-1 in TNF-induced activities and cell types involved in IL-1 actions (submitted for publication).
22. Libert C, Van Bladel S, Brouckaert P, Shaw A, Fiers W. Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor. J Immunol 1991;146:2625-32.
23. Decker K, Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 1974;71:77-106.
24. Huber M, Beutler B, Keppler D. Tumor necrosis factor α stimulates leukotriene production in vivo. Eur J Immunol 1988;18:2085-8.
25. Scuderi P, Dorr RT, Liddil JD, et al. Alpha-globulins suppress human leukocyte tumor necrosis factor secretion. Eur J Immunol 1989;19:939-42.
26. Schade UF, Ernst M, Reinke M, Wolter DT. Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo. Biochem Biophys Res Commun 1989; 159:748-54.
27. Ferraiolo BL, Moore JA, Crase D, Gribling P, Wilking H, Baughman RA. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-α in mice. Drug Metab Dispos 1988;16:270-5.
28. Lazar G, Agarwal MK. The influence of a novel glucocorti-coid antagonist on endotoxin lethality in mice strains. Biochem Med Metab Biol 1986;36:70-4.
29. Waage A. Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. Clin Immunol Immunopathol 1987;45:348-55.
30. Starnes HF Jr, Pearce MK, Tewari A, Yim JH, Zou J-C, Abrams JS. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-α challenge in mice. J Immunol 1990;145:4185-91.